| 0 | 💬 0 |
Combination therapy with tobevibart and elebsiran potently reduces hepatitis B virus surface antigen levels in preclinical in vivo models.
(journals.asm.org)
|
Antimicrobial Agents and Chemotherapy 2026-03-04 | #antibody #antiviral #rnai #hepatitis b #combination therapy |